Developing a core outcome set for pharmacist-led interventions in chronic kidney disease
Development of a Core Outcome Set for Pharmacist-led Interventions in Chronic Kidney Disease: a Protocol for a Survey and e-Delphi Consensus Study
This study is trying to figure out the most important results to measure when pharmacists help people with chronic kidney disease to make their care better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Leicester Academic / other |
| Locations | 1 site (Leicester, Leicestershire) |
| Trial ID | NCT05987280 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a core outcome set for pharmacist-led interventions in patients with chronic kidney disease (CKD). By utilizing the eDelphi method, the study will gather input from various stakeholders, including pharmacists, researchers, healthcare providers, and patients, to identify and standardize the outcomes that matter most in CKD management. The goal is to address the variability in reported outcomes and improve the quality of evidence in this area, ultimately enhancing the effectiveness of pharmacist interventions.
Who should consider this trial
Good fit: Ideal candidates for this study include pharmacists, researchers, healthcare providers, and patients living with chronic kidney disease, as well as their caregivers.
Not a fit: Patients who do not fall into the categories of stakeholders defined for participation, such as those not involved in CKD management or without a connection to pharmacy, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more consistent and effective pharmacist-led interventions for patients with chronic kidney disease.
How similar studies have performed: While there have been studies on pharmacist interventions in CKD, this approach to standardizing outcomes through a core outcome set is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: The stakeholders that will be invited to participate in this survey include: 1) self-defined pharmacists involved in the care of kidney patients and non-renal pharmacists; 2) self-defined researchers involved in CKD and pharmacy research; 3) self-defined nurses and physicians involved in CKD management; 4) self-defined people living with kidney disease; and 5) their carers and/or family members. It is likely that participants will not fit into distinct homogeneous groups; for example, researchers may also be registered pharmacists. Participants will answer questions relevant to their group. All participants over the age of 18 will be invited to take part in the survey Exclusion criteria: Any participants not self-defined as one of the above five groups.
Where this trial is running
Leicester, Leicestershire
- Thomas Wilkinson — Leicester, Leicestershire, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Thomas Wilkinson, PhD
- Email: tjw26@le.ac.uk
- Phone: 07538494193
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.